The global refurbished computers and laptops market is set for robust growth driven by the dual tailwinds of affordability and sustainability, as enterprises, educational institutions, and consumers pivot toward certified pre‑owned devices with warranties and assured quality standards. Recent analyses indicate the market is expanding at high single to low double‑digit rates through 2030–2031, underpinned by rising digital inclusion initiatives, growth of OEM‑backed refurbishment channels, and mounting pressure to reduce e‑waste across regions.

Market Overview

• Multiple reputable sources estimate the global refurbished computers and laptops market size in the high single‑digit billions in 2024–2025, with projections toward mid‑to‑high teens billions by 2030 on a near XXXX CAGR trajectory depending on methodology and scope.
• Analysts highlight expanding certified programs from leading brands and marketplaces—such as Apple, Dell, HP, Lenovo, Amazon Renewed, Best Buy, and specialized platforms like Back Market—improving buyer trust via testing protocols and warranty support.
• Sustainability imperatives and circular economy policies in regions like Europe are accelerating adoption, with several reports citing Europe as a leading or fast‑growing region due to policy support and mature take‑back/refurb ecosystems.

Key Growth Drivers

• Cost optimization: Refurbished devices offer significant savings versus new units while meeting performance requirements for mainstream business and education workloads, expanding adoption among price‑sensitive segments and budget‑constrained institutions.
• Sustainability and e‑waste reduction: Heightened awareness of e‑waste and resource recovery is pushing organizations toward circular procurement models, with refurbishment recognized as a practical lever to extend device lifecycles.
• OEM and retailer certifications: The proliferation of vetted, warranty‑backed refurb channels from global brands and retailers lowers perceived risk and enhances standards for testing, grading, and after‑sales support.

Download Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00019494

Market Size and Forecast Highlights

• Analysts report the market generated approximately USD XXXX billion around 2023–2025 and could reach roughly USD XXXX billion by 2030–2033, implying sustained high single‑digit to low double‑digit growth depending on coverage (device scope, channels, and regions).
• Select long‑range forecasts extend to 2031, with scenarios pointing to strong double‑digit momentum in segments and regions where certified programs and online marketplaces expand fastest.

Competitive Landscape

• Leading participants include Apple, Dell, HP, Lenovo, and channel players such as Amazon Renewed and Best Buy, with regionally focused refurbishers and specialists augmenting supply and service capabilities.
• Competitive strategies span certified pre‑owned portfolios, warranty enhancements, dedicated refurbished storefronts, and regional expansion—exemplified by initiatives like ASUS’s refurbished offerings in India—to capture demand in value‑oriented markets.

Regional Insights

• Europe: Frequently cited as a leading region due to supportive regulations and circular economy initiatives, with strong contributions from the UK, Germany, and France.
• Asia Pacific: Projected outperformance in certain forecasts, supported by digital inclusion priorities, growing SME adoption, and expanding OEM programs.
• Americas and other regions: Stable growth driven by enterprise refresh cycles, education device programs, and marketplace penetration.

Segment Trends

• Laptops remain a focal point for refurbishment due to high refresh volumes, mobile productivity needs, and strong demand from students and hybrid workers.
• Certified grading standards and extended warranties are differentiators, with buyers increasingly prioritizing condition transparency, battery health metrics, and return policies.

Outlook
With affordability, sustainability, and reliability converging, the refurbished computers and laptops market is poised for continued expansion as buyers prioritize total cost of ownership and environmental impact without compromising on quality or support. As OEM‑certified channels and specialized marketplaces scale globally, participants that invest in rigorous testing, transparent grading, and warranty‑backed propositions are positioned to gain share through 2030 and beyond.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Canned Fish Market set to grow steadily on convenience, health, and sustainability trends through 2031 and beyond, led by tuna, salmon, sardines, and mackerel segments across retail and foodservice channels.

Market overview

The global canned fish market is estimated at approximately USD XXXX–XXXX billion in 2025, with forecasts ranging from USD XX–XX billion by 2030–2031 as convenience, shelf stability, and omega-3 nutrition sustain demand growth across mature and emerging regions. Growth projections vary by source, with CAGR outlooks between roughly XX% and XX% through 2030, reflecting differing baselines and segment definitions across syndicated studies. Within the broad category, “tinned fish” formats such as sardines, mackerel, anchovies, and salmon are seeing renewed interest, supported by premium positioning and culinary trends in Europe and North America.

Key growth drivers

• Convenience and pantry loading continue to underpin category resilience, with ready-to-eat formats appealing to busy households and younger demographics seeking quick proteins.
• Health positioning—high protein and omega-3 content—supports trade-up to higher-quality and sustainably sourced SKUs, reinforcing repeat purchase behavior.
• Expanding omnichannel retail and e-commerce penetration improve accessibility and assortment, particularly for premium and niche species/pack sizes.

Market dynamics

Canned fish manufacturers are prioritizing sustainable sourcing, certifications, and traceability to meet retailer and consumer expectations while mitigating supply risks in tuna and salmon value chains. Premiumization via olive oil-packed variants, flavored fillets, and clean-label recipes helps offset input inflation and supports margin defense. Innovation in packaging and mercury-management/quality-monitoring technologies is emerging as a differentiator for premium brands and private labels.

Download Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00019531

Segment insights

• Product mix: Tuna remains the cornerstone globally, with salmon, sardines, and mackerel expanding on health and culinary trends; shellfish exhibits moderate growth from a smaller base.
• Channels: Supermarkets/hypermarkets lead volume; e-commerce supports discovery of premium and sustainable brands and enables direct-to-consumer subscription models.
• Regions: North America and Europe remain large profit pools; Asia Pacific and Latin America show faster growth driven by urbanization and rising disposable income.

Regional highlights

India’s canned seafood market is projected to reach roughly USD XX billion by 2030, growing at about XX% CAGR, with fish as the largest and fastest-growing segment as modern retail expands. The United States, Japan, China, Spain, and Thailand are cited among top contributing countries to global canned seafood demand, reflecting both consumption and processing strengths.

Competitive landscape

The market is moderately consolidated with global leaders leveraging scale, brands, and integrated supply chains, while insurgent players differentiate on sustainability, provenance, and flavor innovation. Representative players across canned fish include Thai Union Group, StarKist, Maruha Nichiro, Bolton Group (Rio Mare), Bumble Bee, Trident Seafoods, Century Pacific Food, Wild Planet, King Oscar, and John West, among others. Strategic activity includes product innovation, collaborations, and M&A to deepen category presence and optimize portfolios across regions and channels.

Recent developments

• Premium line extensions in salmon and tuna are broadening assortments in olive oil and clean-label formats to capture health-conscious shoppers in developed markets.
• New product collaborations and snack kits are expanding usage occasions and on-the-go consumption for younger cohorts.
• Corporate actions and acquisitions continue to reshape brand portfolios and processing footprints, aiming for efficiency and category leadership.

Outlook

From 2025–2030, category growth is expected to remain steady as brands align with sustainability standards, elevate quality cues, and localize flavor innovation, while managing supply constraints in key species. By 2030–2032, the market is projected to reach the mid‑USD 40 billions, with upside tied to premiumization, eco-label adoption, and continued e-commerce expansion across developed and emerging economies.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

The Global Cattle Feed Concentnrate Market is expected to register a CAGR of 3.85% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The global Cattle Feed Concentrate Market is set for steady growth as dairy and beef producers accelerate the shift toward high-efficiency nutrition, precision feeding, and fortified formulations to improve milk yield, weight gain, and herd health outcomes. Market analyses indicate that concentrates remain the leading product class within the broader cattle feed category, supported by sustained demand in Asia-Pacific and the Americas and ongoing upgrades in feed formulation science.

Market Overview

• Concentrates account for the largest share within cattle feed, propelled by performance-focused rations rich in proteins, energy, vitamins, and minerals to boost milk production and feed conversion efficiency.
• The broader cattle feed market is projected to expand through the next decade on the back of rising beef and dairy consumption, precision nutrition, and regulatory emphasis on feed safety and quality, underpinning concentrate adoption across commercial operations.
• Asia Pacific leads cattle feed demand due to herd scale, rapid livestock commercialization, and government support, creating a favorable environment for concentrate penetration in both organized and semi-organized dairy value chains.

Download Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00019554

Growth Drivers

• Rising output targets in dairy and beef: Producers are adopting concentrates to enhance milk yield, fat percentage, and growth rates while maintaining herd health, particularly in intensive and semi-intensive systems.
• Advances in animal nutrition: Innovation in amino acid balancing, micronutrient fortification, and pelletized/mash formulations improves palatability, digestibility, and consistent intake—key for ration optimization with concentrates.
• Regulatory and quality focus: Feed safety frameworks and producer education are boosting compound feed usage and standardized concentrate blends to reduce variability and improve performance outcomes.

Key Market Trends

• Precision feeding and customized rations: Formulation tailoring by production stage (early lactation, mid-lactation, dry period, beef finishing) is gaining momentum for concentrate inclusion strategies that optimize energy-protein balance and cost-per-liter metrics.
• Shift to commercial compound feed: Commercial farms increasingly prefer ready-to-feed concentrate blends and pellets for uniformity, feed efficiency, and labor savings versus on-farm mixing of raw ingredients.
• Sustainability-linked nutrition: Efficiency gains from concentrates are aligned with lower feed waste and improved feed conversion ratios, supporting environmental and economic targets in intensive dairy clusters.

Segmentation Highlights

• By Livestock: Dairy cattle remain the primary end user of concentrates for lactation performance and milk component optimization; beef cattle utilize concentrates in finishing diets to accelerate weight gain and carcass quality.
• By Form: Pellets and mash dominate due to handling ease and intake consistency, with extruded feeds used selectively for digestibility enhancements in high-performance herds.
• By Distribution: Organized commercial channels and integrated feed mills are expanding reach in growth markets, complementing cooperative and dealer networks for last-mile delivery.

Regional Insights

• Asia Pacific: China and India anchor demand with large dairy bases, rising per capita dairy consumption, and supportive policies for compound feed and herd productivity upgrades, driving concentrate usage.
• North America: Strong emphasis on ration precision, feed additive innovation, and large-scale operations sustains concentrate utilization in both dairy and beef systems.
• Latin America and Europe: Brazil’s beef sector and EU’s high-quality milk standards reinforce adoption of formulated concentrates for performance and compliance objectives.

Outlook

With concentrates continuing to outperform roughage-only systems on productivity metrics, the market is poised for consistent growth supported by milk yield optimization, herd health goals, and feed standardization, particularly across Asia-Pacific and North America. As precision nutrition and sustainability considerations intensify, concentrate formulations tailored by stage of production and local feed resource availability will remain central to herd profitability strategies.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

The Global Pyrazolone Market is expected to register a CAGR of 5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

Key Points

• Market supported by expanding use of pyrazolone derivatives in pharmaceuticals for analgesic and anti-inflammatory therapies alongside industrial coloring agents in textiles and plastics.
• Growth underpinned by rising chronic inflammatory disease burden and healthcare spending, plus industrial uptake in dyes and pigments.
• Regional momentum strongest in North America, Europe, and accelerating Asia-Pacific markets given pharma capacity and industrialization.
• Competitive focus includes pharma-grade purity, sustainable synthesis, and compliance with tightening regulatory frameworks.

Market Overview

Industry sources indicate the global pyrazolone market sits in the mid-hundreds of millions of dollars today, with trajectories pointing to sustained single-digit growth anchored by pharma-grade demand for drug intermediates and specialty formulations. Select estimates place market value around the USD XXX–XXX million range in the near term, with various forecasts spanning mid-single to low-double-digit CAGR depending on scenario and timeframe, reflecting differing assumptions on pharma uptake and derivative innovation. Broader trendlines are consistent: pharma-grade leads by value, industry-grade serves dyes and pigments, and innovation in synthesis routes is becoming a differentiator.

Key Growth Drivers

• Pharma demand: Pyrazolone is a core motif in multiple approved and investigational therapeutics, supporting its role as a valued intermediate for analgesic and anti-inflammatory categories in global pipelines.
• Industrial uses: Pyrazolone derivatives function as coloring agents and intermediates in dyes and pigments across textiles and related sectors, sustaining baseline industrial demand.
• R&D pipeline: Ongoing medicinal chemistry research around pyrazolone scaffolds, including neuro and cardiovascular applications, supports long-term formulation and derivative opportunities.

Download Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00019585

Restraints and Challenges

• Regulatory scrutiny: Tightening compliance for pharmaceutical intermediates and environmental safeguards around certain chemical processes can prolong approvals and add cost.
• Input volatility and substitutes: Rising raw material costs and competition from alternative scaffolds in specific therapeutic or colorant use-cases can temper share gains.

Segment Insights

• By Grade: Pharma-grade holds the largest value share due to purity and specification requirements in drug development and manufacturing, outpacing industry-grade volumes on margin and compliance needs.
• By Application: Anti-inflammatory/analgesic pathways remain the core pharma application, while coloring agents comprise the principal industrial lane across dyes and plastics.
• By Region: North America and Europe maintain strong baselines on established pharma ecosystems, while Asia-Pacific—particularly China and India—scales fastest on manufacturing and healthcare expansion.

Competitive Landscape

A mix of catalog chemistry, intermediates suppliers, and pharma-focused distributors operate in this space, with active players including Synblock, AHH Chemical, BOC Sciences, ZINC, Ambinter, Mcule, Anward, and Founder Pharma, emphasizing breadth of library, custom synthesis, and compliant supply. Competition increasingly centers on sustainable and efficient synthesis methods, quality systems, and global logistics reliability for pharma-grade materials.

Recent Trends

• Sustainable routes: Shift toward greener synthesis and solvent management to meet regulatory and ESG expectations in pharma supply chains.
• Advanced methodologies: New catalytic and multicomponent strategies reported in literature continue to expand accessible pyrazolone derivatives and efficiency.
• APAC scaling: Capacity additions and contract manufacturing in Asia-Pacific continue to broaden supply options and price competitiveness.

Outlook

Through 2031, sustained demand from pharma intermediates and steady industrial coloring applications should support consistent growth, with upside tied to derivative innovation and expanded therapeutic use-cases for the pyrazolone scaffold. Vendors that invest in compliant pharma-grade capacity, greener synthesis, and resilient supply chains will be best positioned for share gains across North America, Europe, and expanding Asia-Pacific hubs.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

The global Magnetic Resonance Imaging (MRI) Systems Market is projected to grow from USD 14,168.84 million in 2024 to USD 20,333.64 million by 2031, expanding at a CAGR of 5.3% from 2025 to 2031.

Global Market Overview:

The demand for MRI systems continues to rise due to increasing incidences of neurological disorders, cancer, and cardiovascular diseases that require advanced imaging technologies. Innovations such as high-field MRI scanners and AI-powered imaging software are significantly improving diagnostic speed and accuracy. Furthermore, growing healthcare infrastructure in emerging markets is enhancing accessibility and adoption of MRI systems.

AI integration is emerging as a key driver, streamlining image interpretation, boosting diagnostic confidence, and improving overall clinical workflows.

However, high equipment and maintenance costs remain a barrier in resource-limited settings, especially among smaller clinics and diagnostic centers. Despite this, ongoing innovation and healthcare modernization are expected to sustain market growth globally.

Grab Your PDF Sample To Know More

Market Segmentation Insights:

• By Type :
• Closed MRI Systems (dominant)
• Open MRI Systems
• By Field Strength :
• Low-Field
• Mid-Field (leading segment)
• High & Ultra-High Field
• By Mobility :
• Fixed MRI Systems (leading)
• Portable MRI Systems
• By Application :
• Neurology (dominant)
• Oncology, Cardiology, Orthopedics, Gastroenterology, Gynecology, Others
• By End User :
• Hospitals (largest share)
• Specialty Clinics, Diagnostic Imaging Centers, Research Institutes, Others

Key Growth Drivers:

Rise in Chronic Diseases & Neurological Disorders
The increasing global burden of conditions like multiple sclerosis , epilepsy, and Alzheimer’s is fueling MRI demand for accurate early-stage diagnosis. For instance, the WHO reported over 1.8 million people living with multiple sclerosis globally as of 2023.

Technological Advancements
Innovations in gradient performance , image quality, and AI-assisted diagnosis are transforming the MRI landscape, making it faster, safer, and more accurate.

Key Players:

• GE HealthCare
• Siemens Healthineers AG
• FUJIFILM Holdings Corporation
• Canon Inc.
• Koninklijke Philips N.V.
• Hyperfine, Inc.
• Esaote SpA
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Recent Market Developments:

May 12, 2025 – GE HealthCare launched SIGNA Sprint , a next-gen wide-bore 1.5T MRI system, at ISMRM 2025, offering superior performance and imaging flexibility.

About Us:
Business Market Insights provides reliable, data-rich industry reports across verticals like Healthcare, Electronics, Aerospace, Automotive, Chemicals, and more. Our analysts bring deep sectoral expertise, ensuring credible and actionable insights.

The global laparoscopes market is poised for significant growth, projected to reach US$ 6,746.51 million by 2031 , up from US$ 3,535.70 million in 2024 , growing at a robust CAGR of 9.7% between 2025 and 2031.

Executive Summary & Market Overview

The market is witnessing strong momentum due to:

• The widespread adoption of high-definition (HD), 3D, and 4K laparoscopes
• Increasing volume of minimally invasive procedures
• Rise in same-day surgeries and outpatient care demand

Technological advancements, such as 4K and 3D imaging systems, are reshaping the surgical landscape. 4K systems offer four times the resolution of HD, enhancing precision and image clarity, despite higher costs. A 2024 systematic review of 23 randomized trials found 3D laparoscopes reduced operative time and potential blood loss. However, recent NCBI studies (2025) suggest some clinicians may favor 4K systems for visual clarity, despite mild side effects.

Download Free Sample PDF : Click Here

Executive Summary and Global Market Analysis:

The global laparoscopes market is experiencing significant growth driven by shift toward high-definition visualization, growing laparoscopic procedure volume, and surge in same-day surgeries. Laparoscopic devices encompass rigid laparoscopes, flexible laparoscopes, and robot-assisted laparoscopes. This segment's leading position is bolstered by the advancement of High-Definition (HD), 3D, and 4K laparoscopes, rapidly becoming the standard of care.

Market Segmentation Overview

By Product:

• Rigid Laparoscopes (largest market share in 2024)
• Flexible Laparoscopes
• Robot-Assisted Laparoscopes

By Application:

• General Surgery (leading segment)
• Bariatric Surgery
• Gynecological Surgery
• Colorectal Surgery
• Others

By End User:

• Hospitals & Clinics (dominant in 2024)
• Ambulatory Surgical Centers

Growth Drivers and Opportunities

High-Definition Imaging as a Game Changer

The shift to HD and 4K systems has improved laparoscopic surgery precision. Earlier systems often lacked resolution, creating difficulties in complex dissections. Today, enhanced visualization minimizes surgical errors and improves outcomes.

Key Market Players

• Medtronic Plc
• Johnson & Johnson
• Olympus Corp
• Stryker Corp
• Karl Storz SE & Co KG
• Boston Scientific Corp
• B Braun SE
• Smith & Nephew Plc
• Conmed Corp
• Intuitive Surgical Inc

Report Coverage

This report provides in-depth analysis, including:

• Global, regional, and country-level forecasts
• Key market trends and dynamics
• SWOT analysis
• Competitive landscape with heatmap analysis
• Detailed company profiles
• Regulatory and reimbursement frameworks

About Us

Business Market Insights delivers in-depth, data-rich market intelligence across verticals such as healthcare, electronics, automotive, aerospace, and chemicals. Our expert research and actionable insights support strategic decisions globally.

The global cancer chemotherapy market is poised for substantial growth — projected to reach US$ 84,044.04 million by 2031 from US$ 39,509.70 million in 2024 , registering an impressive CAGR of 11.5% from 2025 to 2031.

Executive Summary & Market Dynamics:

The global cancer chemotherapy market is experiencing significant growth driven by rising global incidence of cancer coupled with an aging population, increasing access to oncology care in emerging markets, and combination with surgery, radiation, and targeted therapies. Cancer therapeutics encompasses alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, and others. Chemotherapy can stop or slow down the growth of cells through the cytotoxic ability of drugs

Growth is fueled by the rising global incidence of cancer , an aging population , and expanding access to oncology care , particularly in emerging markets. Chemotherapy — encompassing alkylating agents , antimetabolites , anti-tumor antibiotics , topoisomerase inhibitors , and mitotic inhibitors — remains a cornerstone of cancer treatment.

According to NIH estimates, around 650,000 cancer patients in the US receive chemotherapy each year. The therapeutic goal: shrink tumors to facilitate surgical removal and improve patient outcomes.

Grab Sample PDF to Learn More:
Download PDF Sample

Market Segmentation:

• By Therapy Type: Alkylating agents dominate, driven by their broad applicability and affordability.
• By Indication: Lung cancer led market share in 2024.
• By Distribution Channel: Hospital pharmacies held the largest share.

Key Growth Driver:

Increased access to oncology care in emerging markets such as Asia-Pacific, Latin America, and parts of Africa is a major driver. Investments in healthcare infrastructure, universal health coverage, and inclusion of chemotherapy drugs in essential medicine lists are improving treatment access significantly.

Leading Companies:

• Astellas Pharma Inc
• Eli Lilly and Co
• Novartis AG
• Merck KGaA
• Johnson & Johnson
• AstraZeneca
• Pfizer Inc
• Bristol Myers Squibb
• F. Hoffmann-La Roche Ltd
• AbbVie

About Us:
Business Market Insights delivers intelligent, data-driven insights across healthcare, automotive, electronics, aerospace, and more—empowering stakeholders to make informed strategic decisions.

The Robot-Assisted Endoscopes Market Size, Share & Global Insights (2021–2031)
The robot-assisted endoscopes market is projected to grow from US$ 292.94 million in 2024 to US$ 515.53 million by 2031 , at a CAGR of 8.4% from 2025 to 2031 .

Executive Summary & Market Insights

As hospitals increasingly adopt advanced, precise, and minimally invasive technologies , robot-assisted endoscopes are seeing rapid uptake—particularly in gastroenterology, urology, gynecology, and thoracic surgery . These systems enable complex procedures with enhanced precision, faster recovery times, and reduced healthcare costs.

The rising burden of chronic diseases like cancer, coupled with a growing preference for less invasive procedures , is driving market expansion.

Download Sample PDF :
Grab Your Copy

Market Segmentation Highlights:

• By Product Type:
  ▪️ Diagnostic
  ▪️ Therapeutic (Dominated in 2024)
• By Application:
  ▪️ Laparoscopy
  ▪️ Colonoscopy
  ▪️ Gastrointestinal Endoscopy (Dominated in 2024)
  ▪️ Others
• By End User:
  ▪️ Hospitals (Largest share in 2024)
  ▪️ Specialty Clinics
  ▪️ Ambulatory Surgical Centers
  ▪️ Others

Market Drivers & Opportunities

✔️ Growing demand for minimally invasive surgeries
✔️ Enhanced surgical precision & visualization
✔️ Surge in chronic conditions (e.g., GI diseases, urological disorders)
✔️ Reduced hospital stays & overall treatment costs

Key Market Players

• Medtronic
• Intuitive Surgical
• Stryker Corporation
• Moon Surgical
• Asensus Surgical
• Meril
• Novus
• MicroPort Scientific Corp

Report Coverage Includes:

• Global, regional, and country-level forecasts
  • Market trends, SWOT & Porter’s Five Forces analysis
  • Competitive landscape and key developments
  • Detailed company profiles

Stay ahead in healthcare innovation.
Powered by: Business Market Insights

About Us

Business Market Insights delivers in-depth, data-rich market intelligence across verticals such as healthcare, electronics, automotive, aerospace, and chemicals. Our expert research and actionable insights support strategic decisions globally.

The global neodymium iron boron (NdFeB) permanent magnet market is projected to grow significantly, reaching US$ 29,129.11 million by 2031 , up from US$ 15,204.23 million in 2024 . This growth reflects a robust CAGR of 10.3% during the forecast period from 2025 to 2031.

Executive Summary & Global Market Analysis

The NdFeB magnet market is witnessing strong momentum, fueled by increasing adoption of high-performance, energy-efficient technologies across diverse industries. These magnets are known for their exceptional magnetic strength, compact size, and versatility—attributes that make them indispensable in electric vehicles (EVs) , wind turbines , consumer electronics , and medical devices .

Key growth drivers include:

• The global transition to renewable energy sources
• Rapid electrification in automotive and industrial sectors
• Miniaturization and automation of electronic devices

Emerging trends such as recycling of rare earth elements , supply chain resilience , and environmental sustainability are reshaping the competitive landscape. Market players are also heavily investing in advanced manufacturing technologies and collaborative R&D to enhance performance and sustainability.

Despite the market’s dominance by established Asian manufacturers, new opportunities are opening for companies that can deliver differentiated value such as higher magnet quality , local supply chains , and lower carbon footprints .

Click Here to Download Sample Report

Market Segmentation Analysis

By Type:

• Sintered NdFeB Magnets (Dominant in 2024)
• Bonded NdFeB Magnets

By End-User:

• Automotive (Leading segment)
• Consumer Electronics
• Power Generators (Wind Turbines)
• Industrial Automation & Robotics
• Medical Devices
• Others

By Geography:

• North America
• Europe
• Asia-Pacific (Leading region)
• Middle East & Africa
• South & Central America

Key Market Drivers and Opportunities

Electrification of Transportation

The increasing adoption of electric vehicles globally is one of the strongest drivers of NdFeB magnet demand. These magnets are critical components in EV motors, offering unmatched energy efficiency and magnetic strength . Regulatory mandates, consumer preferences for cleaner mobility, and infrastructure investments are further fueling this trend.

Industrial Automation and Energy Sector Growth

The global shift toward automation , smart manufacturing , and wind energy generation also significantly contributes to the demand for high-performance NdFeB magnets.

Type-Based Market Insights

Sintered NdFeB magnets held the largest market share in 2024. These magnets are produced using powder metallurgy , providing superior temperature stability , demagnetization resistance , and magnetic performance —ideal for demanding applications in EVs, renewable energy, and robotics.

Key Players in the NdFeB Magnet Market

• Hitachi Metals, Ltd.
• Shin-Etsu Chemical Co., Ltd.
• TDK Corporation
• Ningbo Yunsheng Co., Ltd.
• Beijing Zhong Ke San Huan High-Tech Co., Ltd.
• Vacuumschmelze GmbH & Co. KG
• Neo Performance Materials Inc.

About Us

Business Market Insights provides data-rich intelligence across industries like healthcare, electronics, automotive, aerospace, and chemicals. Our actionable insights help global stakeholders make informed strategic decisions.

The global Magnetic Resonance Imaging (MRI) Systems Market is projected to grow from USD 14,168.84 million in 2024 to USD 20,333.64 million by 2031, expanding at a CAGR of 5.3% from 2025 to 2031.

Global Market Overview:

The demand for MRI systems continues to rise due to increasing incidences of neurological disorders, cancer, and cardiovascular diseases that require advanced imaging technologies. Innovations such as high-field MRI scanners and AI-powered imaging software are significantly improving diagnostic speed and accuracy. Furthermore, growing healthcare infrastructure in emerging markets is enhancing accessibility and adoption of MRI systems.

AI integration is emerging as a key driver, streamlining image interpretation, boosting diagnostic confidence, and improving overall clinical workflows.

However, high equipment and maintenance costs remain a barrier in resource-limited settings, especially among smaller clinics and diagnostic centers. Despite this, ongoing innovation and healthcare modernization are expected to sustain market growth globally.

Grab Your PDF Sample To Know More

Market Segmentation Insights:

• By Type :
• Closed MRI Systems (dominant)
• Open MRI Systems
• By Field Strength :
• Low-Field
• Mid-Field (leading segment)
• High & Ultra-High Field
• By Mobility :
• Fixed MRI Systems (leading)
• Portable MRI Systems
• By Application :
• Neurology (dominant)
• Oncology, Cardiology, Orthopedics, Gastroenterology, Gynecology, Others
• By End User :
• Hospitals (largest share)
• Specialty Clinics, Diagnostic Imaging Centers, Research Institutes, Others

Key Growth Drivers:

Rise in Chronic Diseases & Neurological Disorders
The increasing global burden of conditions like multiple sclerosis , epilepsy, and Alzheimer’s is fueling MRI demand for accurate early-stage diagnosis. For instance, the WHO reported over 1.8 million people living with multiple sclerosis globally as of 2023.

Technological Advancements
Innovations in gradient performance , image quality, and AI-assisted diagnosis are transforming the MRI landscape, making it faster, safer, and more accurate.

Key Players:

• GE HealthCare
• Siemens Healthineers AG
• FUJIFILM Holdings Corporation
• Canon Inc.
• Koninklijke Philips N.V.
• Hyperfine, Inc.
• Esaote SpA
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Recent Market Developments:

May 12, 2025 – GE HealthCare launched SIGNA Sprint , a next-gen wide-bore 1.5T MRI system, at ISMRM 2025, offering superior performance and imaging flexibility.

About Us:
Business Market Insights provides reliable, data-rich industry reports across verticals like Healthcare, Electronics, Aerospace, Automotive, Chemicals, and more. Our analysts bring deep sectoral expertise, ensuring credible and actionable insights.